Gut bacteria composition in animal models of Parkinson's disease: a systematic review and meta-analysis [0.03%]
帕金森病动物模型肠道菌群组成：系统评价和荟萃分析
Joshua D Elford,Elise J Heesbeen,Nienke A van der Plaats et al.
Joshua D Elford et al.
The gut microbiome is believed to play an important role in the development and onset of Parkinson's disease (PD). While human studies report differences in gut microbiota between PD individuals and healthy controls, it is unclear whether p...
Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy [0.03%]
系统评估线粒体形态调节因子以改善神经元α-突触核蛋白病
Su Yeon Kim,JunYoung Choi,Dong Cheol Jang et al.
Su Yeon Kim et al.
Neuronal mitochondria display distinct morphologies across compartments, with dendritic mitochondria being elongated and axonal ones shorter, and their morphologies are dynamically changed via fusion and fission machineries. Mitochondrial s...
Lu Lin,Jin Li,Si Zhu et al.
Lu Lin et al.
With the intensification of global plastic pollution, the potential threats posed by micro- and nanoplastics (MPs/NPs) to human health have become a major concern. MPs/NPs enter the organism through ingestion, inhalation, and skin contact, ...
Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson's disease [0.03%]
评估神经营养肽混合物在帕金森病病理治疗中的作用
Dmytro Krasnienkov,Iryna Karaban,Nina Karasevych et al.
Dmytro Krasnienkov et al.
This exploratory, single-group, open-label study investigated 17 patients with Parkinson's disease (PD) using a pre-post design. Motor and non-motor outcomes were assessed through clinical scales, biochemical and genetic analyses, and machi...
Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons disease [0.03%]
皮层诱发电位在帕金森病丘脑底核电刺激参数优化中的临床应用价值研究
Blake Hale,Anna Latorre,Lorenzo Rocchi et al.
Blake Hale et al.
Optimal subthalamic nucleus deep-brain stimulation (STN-DBS) for Parkinson's disease reduces motor symptoms without stimulating adjacent structures and causing side-effects. Fine-tuning STN-DBS using clinical evaluation is time-consuming an...
Optimizing Parkinson's disease progression scales using computational methods [0.03%]
利用计算方法优化帕金森病进展量表
Assaf Benesh,Roy N Alcalay,Anat Mirelman et al.
Assaf Benesh et al.
Parkinson's disease (PD) is a highly heterogeneous condition with symptoms spanning motor and non-motor domains. Clinical scales like the Movement Disorder Society's Unified Parkinson's Disease Rating Scale (MDS-UPDRS) are standard in clini...
Kara A Johnson,Patricia B Coutinho,Lauren E Kenney et al.
Kara A Johnson et al.
Depression is increasingly recognized as a prevalent source of disability in individuals with Parkinson's disease (PD), but its pathophysiology is not well understood. Neural activity in the basal ganglia, particularly the subthalamic nucle...
Comparative effects of medication combined with twenty rehabilitation therapies: core outcomes in 8202 parkinson's patients [0.03%]
药物联合二十种康复治疗的对比效果：8202例帕金森病患者核心指标分析
Haojie Li,Xinyu Lin,Rui Huang et al.
Haojie Li et al.
Parkinson's disease (PD) is a neurodegenerative disorder with complex motor and non-motor symptoms. This network meta-analysis evaluated the combined effects of medication and 20 rehabilitation therapies on motor function, neuro-psychiatric...
Magnetoencephalography-based prediction of longitudinal symptom progression in Parkinson's disease [0.03%]
基于脑电磁图的帕金森病纵向症状进展预测
Josefine Waldthaler,Igori Comarovschii,Daniel Lundqvist
Josefine Waldthaler
Motor dysfunction in Parkinson's disease (PD) has been linked to widespread oscillatory changes within the basal ganglia-thalamic-cortical network, particularly in the beta frequency range. However, the evolution of cortical neurophysiologi...
Author Correction: The genetic architecture of Parkinson's disease on the Island of Crete [0.03%]
作者更正：克里特岛帕金森病的遗传结构
Iro Boura,Shaimaa Sait,Nikolaos M Marinakis et al.
Iro Boura et al.
Published Erratum
NPJ Parkinson's disease. 2026 Jan 21;12(1):22. DOI:10.1038/s41531-026-01267-1 2026